A Study to Evaluate the Mode of Administration and Safety of EUR-1008 (APT-1008) in Infants 1 to 12 Months of Age

Clinical trial NCT01100606 · COMPLETED

Trial details

NCT number: NCT01100606
Sponsor: Forest Laboratories
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Cystic Fibrosis Exocrine Pancreatic Insufficiency

Start date: 2010-06-01
Primary completion: 2010-12-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.